Methylene Blue and UTIs: What You Need to Know

Methylene blue is not a treatment for urinary tract infections (UTIs). It is not an antibiotic and has no significant antibacterial activity against uropathogens at therapeutic doses.

Approved Uses

  • Methemoglobinemia: Antidote (reduces Fe³⁺ to Fe²⁺ in hemoglobin). IV 1–2 mg/kg.
  • Diagnostic Dye: Sentinel lymph node mapping, parathyroid surgery, fistula localization.
  • Ifosfamide Neurotoxicity Prophylaxis/Treatment: Inhibits formation of neurotoxic metabolite.
  • Historical: Malaria, cyanide poisoning, carbon monoxide poisoning (obsolete).

Urinary Effects

  • Excreted renally → turns urine blue-green. Used historically as a urinary antiseptic (early 1900s) but ineffective by modern standards.
  • Can interfere with urine dipstick tests (false positive leukocyte esterase, protein).

UTI Treatment

First-line antibiotics (guided by local resistance):

  • Uncomplicated Cystitis: Nitrofurantoin 100 mg BID 5d, TMP-SMX DS BID 3d (if resistance <20%), Fosfomycin 3g single dose.
  • Complicated/Pyelonephritis: Fluoroquinolones, cephalosporins, carbapenems, aminoglycosides — IV/oral per severity.

Safety Warning

  • Serotonin Syndrome Risk: Methylene blue is a potent MAO-A inhibitor. Contraindicated with SSRIs, SNRIs, MAOIs, linezolid, triptans.
  • G6PD Deficiency: Can cause hemolysis.
  • Pregnancy: Category X (fetal harm).

Do not self-treat UTI with methylene blue. See a clinician for appropriate antibiotics.

Urinary Disorders - Related Articles